AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01807832 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: capsaicin challenge
Study NCT02469961 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interscalene block
Description: Interscalene block is used for the main anesthetic for the case
Study NCT04475939 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Niraparib
Description: Niraparib will be administered.
Study NCT04475939 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab will be administered
Study NCT03241173 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab will be administered IV at the protocol-defined dose according to assigned treatment group.
Study NCT04475939 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Pembrolizumab
Description: Pembrolizumab will be administered
Study NCT04475939 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo will be administered
Study NCT04563260 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline injection
Description: Normal saline 2 mL, intravenous injection
Study NCT03241173 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Ipilimumab will be administered IV at the protocol-defined dose according to assigned treatment group.
Study NCT03891576 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Niraparib
Description: Niraparib is a potent, orally active PARP1 and PARP2 inhibitor being developed as a treatment for patients with tumors that harbor defects in the homologous recombination DNA repair pathway or that are driven by PARP-mediated transcription factors.
Study NCT03891576 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Niraparib
Description: Niraparib is a potent, orally active PARP1 and PARP2 inhibitor being developed as a treatment for patients with tumors that harbor defects in the homologous recombination DNA repair pathway or that are driven by PARP-mediated transcription factors.
Study NCT03891576 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Niraparib
Description: Niraparib is a potent, orally active PARP1 and PARP2 inhibitor being developed as a treatment for patients with tumors that harbor defects in the homologous recombination DNA repair pathway or that are driven by PARP-mediated transcription factors.
Study NCT03133559 — intervention group
Intervention type: OTHER
Intervention: Observational
Description: We will use a deep phenotyping approach to collect multidimensional datasets from individuals infected with HIV compared to healthy controls to define circadian rhythm disruptions associated with HIV infection.
Study NCT01050101 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: No fiber
Description: The High GI low fiber meal consists of 0 grams fiber with total kcal of 573 with 63% energy from carbohydrates, 24% energy from fat and 13% energy from protein.~Test meal consists of breakfast meals containing muffins and yogurt beverage/shake.
Study NCT01050101 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Low GI high fiber viscous meal
Description: Test meal consists of 12 grams of fiber (9 grams soluble and 3 grams insoluble). The ratio is 80:20 ratio of viscous polysaccharide fiber source (psyllium husk) to insoluble non-viscous producing fiber source (cellulose).~Total kcal provided as 560 kcal with 63% energy from carbohydrates, 24% energy from fat and 13% energy from protein. Test meal consists of breakfast meals containing muffins and yogurt beverage/shake.
Study NCT01050101 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Low GI high fiber non-viscous
Description: Test meal consists of 11 grams of fiber (3 grams soluble and 8 grams insoluble). The ratio is 20:80 of viscous polysaccharide fiber source (psyllium husk) to insoluble non-viscous producing fiber source (cellulose).~Total kcal provided as 560 kcal with 63% energy from carbohydrates, 24% energy from fat and 13% energy from protein. Test meal consists of breakfast meals containing muffins and yogurt beverage/shake.
Study NCT02999971 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: circuit class therapy in water
Description: The circuit, the main part of the session, include a series of 10 different workstations, arranged to progress in complexity, in order to work several segments of the body, oriented towards a functional recovery objective. These stations will be made up of task-specific activities for gait, balance and dexterity. Time in each workstation will be 5 minutes divided as follows: 4 minutes work period and 1 minute rest period, of these, last 30 seconds will be change period for crossing from one workstation to the next. After 50 minutes, each patient will have covered the 10 workstations, thus working in all of the objectives pursued in the realization on this CCT: gait, balance and dexterity.
Study NCT02999971 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: circuit class therapy on land
Description: The circuit, the main part of the session, include a series of 10 different workstations, arranged to progress in complexity, in order to work several segments of the body, oriented towards a functional recovery objective. These stations will be made up of task-specific activities for gait, balance and dexterity. Time in each workstation will be 5 minutes divided as follows: 4 minutes work period and 1 minute rest period, of these, last 30 seconds will be change period for crossing from one workstation to the next. After 50 minutes, each patient will have covered the 10 workstations, thus working in all of the objectives pursued in the realization on this CCT: gait, balance and dexterity.
Study NCT01005628 — intervention group
Intervention type: DRUG
Intervention: bortezomib
Description: Injection into a vein 1.3 mg/m2 twice a week for 21 days
Study NCT04908436 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Finerenone (BAY94-8862)
Description: 10 mg BAY94-8862 immediate release (IR) tablet, administered orally
Study NCT03591861 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Description: * Children under 2 years will immediately start on a full calorie classical 3:1 ketogenic diet. The 3:1 ratio indicates that the diet contains 3 g of fat for every 1 g of protein + carbohydrate, which results in about 87% of calories coming from fat.~* Children 2 years or older will skip breakfast and lunch on the day of admission but start a full calorie 3:1 ketogenic diet at dinner.
Study NCT03591861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BCNU
Description: -Standard of care
Study NCT01550575 — intervention group
Intervention type: DEVICE
Intervention: Non Boston Scientific Systems
Description: Spinal cord stimulation, RF, IDS etc.
Study NCT01550575 — intervention group
Intervention type: DEVICE
Intervention: Boston Scientific Systems
Description: Spinal cord stimulation, RF, IDS etc
Study NCT04796818 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Diffusion Weighted Imaging
Description: Undergo IVIM DWI
Study NCT04145115 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Given IV
Study NCT04145115 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT04145115 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV
Study NCT04563260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palonosetron Injection [Aloxi]
Description: Palonosetron 1.5 mL (0.075 mg) + Normal saline 0.5 mL, intravenous injection
Study NCT00107107 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: pramlintide acetate
Description: Syringe vial and Pen-cartridge
Study NCT02616822 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Trans-resveratrol
Description: Used for trans-resveratrol substance 300 mg single dose
Study NCT02616822 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Used for placebo substance single dose
Study NCT04021862 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bermekimab Monoclonal Antibody
Description: Bermekimab 400 mg or 800 mg will be administered subcutaneously.
Study NCT04021862 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered subcutaneously.
Study NCT04021862 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered subcutaneously.
Study NCT03991377 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Eye movement desensitization and reprocessing therapy
Description: EMDR is an integrative psychotherapy that uses standardized protocols and elements of cognitive-behavioral, interpersonal, and body-centered therapies, as well as dual stimulation (e.g., side-to-side eye movements).~The current standard protocol includes eight phases:~1. Patient history.~2. Patient preparation.~3. Patient assessment.~4. Memory desensitization.~5. Installing the positive cognition.~6. Body scan.~7. Closure.~8. Reevaluation.
Study NCT03991377 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment as usual
Description: Once patients are discharged from hospital, they will be treated by the multidisciplinary team of the Specialized Early Intervention Programme for Incipient Psychosis (PAE-TPI) as part of their usual treatment, which consists of a multidisciplinary approach that includes pharmacological treatment and psychological support, from social workers or nursing staff. An individual care plan is drawn up depending on individual needs and may include follow-up psychiatric visits to evaluate clinical status and, if necessary, readjust pharmacological treatment, and psychological visits to assess and detect risk situations and prevent relapses using a non-trauma focused CBT. In no case will psychological treatment focus on PTSD.
Study NCT03991377 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: Once patients are discharged from hospital, they will be treated by the multidisciplinary team of the Specialized Early Intervention Programme for Incipient Psychosis (PAE-TPI) as part of their usual treatment, which consists of a multidisciplinary approach that includes pharmacological treatment and psychological support, from social workers or nursing staff. An individual care plan is drawn up depending on individual needs and may include follow-up psychiatric visits to evaluate clinical status and, if necessary, readjust pharmacological treatment, and psychological visits to assess and detect risk situations and prevent relapses using a non-trauma focused CBT. In no case will psychological treatment focus on PTSD.
Study NCT00806780 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: on table cholangiography
Description: x-ray imaging of common bile duct
Study NCT04083222 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: ISIS 757456-matching placebo solution administered as SC injection.
Study NCT04083222 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ISIS 757456
Description: ISIS 757456 administered as SC injection.
Study NCT00620204 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: atorvastatin
Description: atorvastatin 40mg qd for 1 year
Study NCT02565823 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise bout
Description: Participants will exercise for 45min at 75% of VO2peak
Study NCT03538873 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity
Study NCT03734354 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brexpiprazole
Description: Brexpiprazole , single/oral/with fasting
Study NCT00765635 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: drops intilation (Taponoto ® )
Description: four drops, unique doses
Study NCT00765635 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: drops intilation (Otocerum®)
Description: four drops, unique doses
Study NCT00765635 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: drops intilation (Placebo)
Description: Placebo
Study NCT03279250 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abiraterone Acetate
Description: Given PO
Study NCT03279250 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apalutamide
Description: Given PO
Study NCT04566510 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: long lasting insecticidal nets with alpha-cypermethrin + pyriproxyfen (PPF LLIN, Royal Guard))
Description: Next-generation bed net combining insecticides with different modes of action
Study NCT04566510 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: long lasting insecticidal nets with deltamethrin + piperonyl butoxide (PBO LLIN, PermaNet 3.0))
Description: Next-generation bed net combining an insecticide with a synergist
Study NCT04566510 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social behaviour change communication
Description: SBCC activities will use digital and other platforms, similar to those used for the COVID-19 response, including the following: (1) LLIN launch on television and radio; (2) regional advocacy meetings on Zoom; (3) mass media platforms (for advertisements, mini skits, DJ mentions, radio spots, interactive talks); (4) social media platforms; (5) VHTs; (6) operation hotlines and toll-free call centres; (7) community mobilisation (megaphones); and (8) use of appropriate information, education, and communication materials. Communication will include messages about COVID-19, malaria, and use, care, repair and repurposing of LLINs.
Study NCT04566510 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social behaviour change communication
Description: SBCC activities will use digital and other platforms, similar to those used for the COVID-19 response, including the following: (1) LLIN launch on television and radio; (2) regional advocacy meetings on Zoom; (3) mass media platforms (for advertisements, mini skits, DJ mentions, radio spots, interactive talks); (4) social media platforms; (5) VHTs; (6) operation hotlines and toll-free call centres; (7) community mobilisation (megaphones); and (8) use of appropriate information, education, and communication materials. Communication will include messages about COVID-19, malaria, and use, care, repair and repurposing of LLINs.
Study NCT02769416 — intervention group
Intervention type: OTHER
Intervention: Data and sample repository
Description: Subjects with spinal cord and/or traumatic brain injury, family members and healthy volunteers will provide data and samples.
Study NCT03279250 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Gonadotropin-releasing Hormone Analog
Description: Given IM
Study NCT03984448 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT03984448 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT03984448 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy
Study NCT03984448 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy
Study NCT03984448 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT scan
Study NCT03984448 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan
Study NCT03984448 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide
Description: Given IV
Study NCT03984448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV
Study NCT03984448 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Doxorubicin Hydrochloride
Description: Given IV
Study NCT03984448 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Etoposide
Description: Given IV
Study NCT03984448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV
Study NCT05882162 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coronectomy
Description: Removal of crown part of the mandibular third molar
Study NCT05882162 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Coronectomy
Description: Removal of crown part of the mandibular third molar
Study NCT05882162 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pulp Capping with calcium silicate
Description: Application of a pulp capping material (BiodentineTM, Septodont, St Maur-des-Fosses, France) on pulp tissue to preserve the vitality of the residual pulp and prevent inflammation
Study NCT00375934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: diclofenac potassium (XP21L)
Description: 25 mg capsule, every 6 hours
Study NCT00375934 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral placebo capsule, every 6 hours
Study NCT03442426 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Integrated model of primary care
Description: Intervention includes: 1) consistent risk screening and assessment; 2) care coordination and system navigation; 3) patient/caregiver engagement and shared decision-making; and 4) enabling technology supports.
Study NCT03640897 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Liniderm
Description: Cleaning of the diaper area with Liniderm at each diaper change during 28 days
Study NCT03640897 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Wipes
Description: Cleaning of the diaper area with wipes at each diaper change during 28 days
Study NCT03640897 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Water
Description: Cleaning of the diaper area with water and cotton pads at each diaper change during 28 days
Study NCT04522427 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Use Multifocal and Extended Depth-of-Focus Intraocular Lenses(IOLs)
Description: IOLs include AT LISA tri 839MP, AcrySof IQ PanOptix IOL, TECNIS Symfony EDOF
Study NCT04522427 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Use Monofocal intraocular lenses(IOLs)
Description: Monofocal IOLs include 409(Zeiss), AcrySof, TECNIS IOLS
Study NCT04052958 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: IMT - inspiratory muscle training
Description: respiratory strength or indurance training with respiratory therapy device
Study NCT01019590 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg
Study NCT01019590 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Benicar HCT ® Tablets 40 mg/25 mg
Study NCT01134887 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Informational Guide for Patients
Description: Veterans received a copy of the NIA guide for Talking with Your Doctor. This pamphlet was specifically developed for this purpose (updated in 2002). It has pictorials and is written at an 8th grade level.
Study NCT01134887 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Informational Guide for Patients
Description: Veterans received a copy of the NIA guide for Talking with Your Doctor. This pamphlet was specifically developed for this purpose (updated in 2002). It has pictorials and is written at an 8th grade level.
Study NCT01134887 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video-Assisted Coaching
Description: Physicians participated in an audiotaped intensive 30 minute, one-on-one educational intervention with PI Frankel after their first set of visits from their three participating patients, but before seeing them for follow-ups. The main goal of this video-assisted coaching session was to review and discuss the analysis of the physician's videotaped visits using the Four Habits framework, with a particular focus on improving communication about self-management.
Study NCT01134887 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Monograph for Physicians
Description: Primary care providers randomly assigned to the Intervention-Physicians arm of this study received a copy of the Four Habits of Highly Effective Physicians. The Four Habits provided practical evidence-based advice for improving patient-physician communication.
Study NCT01134887 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational Coaching
Description: an educator met with each Veteran in the intervention arm individually for 20-30 minutes to review the material in the pamphlet and develop a plan for enhancing communication about self-management of hypertension with their doctor \[Coaching\]. To facilitate communication change, the educator assisted the patient in setting a goal to achieve during their visit. The educator also provided telephone follow-up within 24 hours to review satisfaction and effectiveness of the visit and assess barriers and facilitators to communicating about self-management.
Study NCT01134887 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: The primary care providers randomly assigned to the Control-Physicians arm did not receive any additional coaching or resources and conducted their practice as usual.
Study NCT04634968 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Motivational Interviewing interaction
Description: Telephone peer counselling+ Brief Motivational Interviewing interaction, and telephone-based interview after receiving all information.